John Kollins
Direttore operativo presso BioSpace, Inc. (Iowa)
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Richard Geoffrion | M | - |
Cyrano Therapeutics, Inc.
 Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | - |
| Ryoichi Nagata | M | 65 | 1 anni | |
| Mark Kessel | M | 82 |
Symphony ViDA, Inc.
 Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | 4 anni |
| Charles W. Finn | M | - |
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | - |
| Robert I. Henkin | M | - |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | - |
| Detlef F. Albrecht | M | 63 | 7 anni | |
| Mic Iwashima | M | 46 | 7 anni | |
| Joshua Goodwin | M | - |
BioSpace, Inc. (Iowa)
 BioSpace, Inc. (Iowa) Internet Software/ServicesTechnology Services BioSpace, Inc. operates as an online community for industry news and careers for life science professionals. It offers online job board, daily biotech news feeds, and community features connect recruiters, job seekers. The company was founded in March 1995 and is headquartered in Urbandale, IA. | 8 anni |
| Takahide Koda | M | - |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | - |
| Shannon Strom | M | 48 | 6 anni | |
| Robert Schultz | M | 60 | 7 anni | |
| Robert M. Janosky | M | - | 4 anni | |
| Shunji Haruta | M | - | 1 anni | |
| Shinji Nitanda | M | 55 | 1 anni | |
| Shuichi Kanazashi | M | 64 | 1 anni | |
| Jeff S. Edelman | M | - |
Symphony ViDA, Inc.
Symphony ViDA, Inc. Pharmaceuticals: MajorHealth Technology Symphony ViDA, Inc. develops and manufactures biopharmaceutical drugs. Its products are used to treat the multiple forms of cancer and neovascular diseases of the eye. The company was founded in October 2008 and is headquartered in Rockville, MD. | - |
| Gerry Brunk | M | 55 |
Cyrano Therapeutics, Inc.
Cyrano Therapeutics, Inc. Medical SpecialtiesHealth Technology Cyrano Therapeutics, Inc. is a clinical stage regenerative medicine company based in Delray Beach, FL. Cyrano Therapeutics is developing a novel therapy to restore smell and flavor function, with a focus on chronic smell and flavor loss caused by influenza, allergic rhinitis, traumatic brain injury, and COVID-19. The company raised a $12.80m series A financing in December 2020 led by Remiges Ventures and Ventures. The chronic loss of smell and flavor is a condition affecting at least 5% of the population with a similar incidence in and. The company was founded by Robert I. Henkin and Richard Geoffrion, with Richard Geoffrion serving as the CEO since incorporation. | 4 anni |
| Akihisa Mori | M | - | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Peter J. Langecker | M | 73 | 5 anni | |
| Thomas Soloway | M | 55 |
Transcept Pharma, Inc.
 Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 15 anni |
| William Schwieterman | M | 66 | 13 anni | |
| Richard H. Chin | M | 57 | 2 anni | |
| Raj Shah | M | 46 | 7 anni | |
| Thomas O'Neil | M | 59 | 4 anni | |
| Mutya Harsch | F | 50 | 2 anni | |
| Christopher Ehrlich | M | 54 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 4 anni |
| Michael Riebe | M | 63 | 6 anni | |
| Thomas King | M | 69 | 6 anni | |
| Matthew M. Loar | M | 61 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | - |
| Thomas Dietz | M | 60 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 1 anni |
| Elisabeth Sandoval | F | 62 | 4 anni | |
| Heath Lukatch | M | 56 | 7 anni | |
| Hing Leung Sham | M | 71 |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 6 anni |
| Conor Walsh | M | 51 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 2 anni |
| Leone Patterson | F | 61 |
Transcept Pharma, Inc.
Transcept Pharma, Inc. Pharmaceuticals: MajorHealth Technology Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA. | 2 anni |
| Douglas Love | M | 56 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 7 anni |
| Declan O’Connor | M | - |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 12 anni |
| Guriqbal S. Basi | M | 67 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 22 anni |
| Michael G. Kelly | M | - |
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | - |
| Jai Balkissoon | M | - | - | |
| Jeffrey Farrow | M | 62 |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | 4 anni |
| Ted Yednock | M | 66 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 17 anni |
| Michelle Edwards | F | - | 4 anni | |
| Patricia Ann Walicke | M | 71 | 2 anni | |
| Peter A. Harris | M | 80 | 6 anni | |
| Dushyant Pathak | M | - |
Renovis, Inc.
Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | - |
| Roy Hampton Fickling | M | 58 | 4 anni | |
| Joel-Tomas Citron | M | 62 | 7 anni | |
| Sumita Ray | F | 50 |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 3 anni |
| J. Richard Zecher | M | 83 | 5 anni | |
| Alastair J. J. Wood | M | 77 | 5 anni | |
| Julie Patel | F | - |
Elan Pharmaceuticals, LLC
Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | 5 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 52 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John Kollins
- Contatti personali
